A Phase 1, Randomized, Open-label, Crossover Study to Evaluate the Effect of the Organic Anion Transporter Inhibitor Probenecid on the Pharmacokinetics of JNJ-64041575 in Healthy Adult Subjects
Phase of Trial: Phase I
Latest Information Update: 21 Aug 2018
At a glance
- Drugs Lumicitabine (Primary) ; Probenecid
- Indications Metapneumovirus infections; Parainfluenza virus infections; Respiratory syncytial virus infections
- Focus Pharmacokinetics
- Sponsors Janssen-Cilag
- 24 Jul 2017 Status changed from recruiting to completed.
- 12 May 2017 Planned End Date changed from 6 Dec 2017 to 12 Jun 2017.
- 14 Apr 2017 Status changed from not yet recruiting to recruiting.